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Insulin-positive, Glut2-low cells present within mouse pancreas exhibit lineage
plasticity and are enriched within extra-islet endocrine cell clusters
Christine A. Beamisha,d,e, Brenda J. Struttb,e, Edith J. Aranyb,c,d,e, and David J. Hilla,b,d,e
a
Department of Physiology and Pharmacology, Western University, London, ON, Canada; bDepartment of Medicine, Western University, London,
ON, Canada; cDepartment of Pathology, Western University, London, ON, Canada; dChildren’s Health Research Institute, London, ON, Canada;
e
Lawson Health Research Institute, St Joseph Health Care, London, ON, Canada

ABSTRACT

ARTICLE HISTORY

Regeneration of insulin-producing b-cells from resident pancreas progenitors requires an understanding
of both progenitor identity and lineage plasticity. One model suggested that a rare b-cell sub-population
within islets demonstrated multi-lineage plasticity. We hypothesized that b-cells from young mice
(postnatal day 7, P7) exhibit such plasticity and used a model of islet dedifferentiation toward a ductal
epithelial-cell phenotype to test this theory. RIPCre;Z/APC/C mice were used to lineage trace the fate of
b-cells during dedifferentiation culture by a human placental alkaline phosphatase (HPAP) reporter. There
was a signiﬁcant loss of HPAP-expressing b-cells in culture, but remaining HPAPC cells lost insulin
expression while gaining expression of the epithelial duct cell marker cytokeratin-19 (Ck19). Flow
cytometry and recovery of b-cell subpopulations from whole pancreas vs. islets suggest that the
HPAPCCk19C cells had derived from insulin-positive, glucose-transporter-2-low (InsCGlut2LO) cells,
representing 3.5% of all insulin-expressing cells. The majority of these cells were found outside of islets
within clusters of <5 b-cells. These insulinCGlut2LO cells demonstrated a greater proliferation rate in vivo
and in vitro as compared to insulinCGlut2C cells at P7, were retained into adulthood, and a subset
differentiated into endocrine, ductal, and neural lineages, illustrating substantial plasticity. Results were
conﬁrmed using RIPCre;ROSA- eYFP mice. Quantitative PCR data indicated these cells possess an
immature b-cell phenotype. These InsCGlut2LO cells may represent a resident population of cells capable
of forming new, functional b-cells, and which may be potentially exploited for regenerative therapies in
the future.

Received 2 February 2016
Revised 25 February 2016
Accepted 1 March 2016

Introduction
It has been proposed that all new b-cells in the postnatal pancreas arise from pre-existing b-cells, both
across the lifespan and during adaptive responses to
physiological metabolic demands.1,2 However, a contribution from “facultative” progenitor cells, which
may require a stimulus of injury or pathologic metabolic stress, dependent on the maturational status of
cells, is also potentially important.3 This is supported
by the reported presence of progenitor b-cells with
multi-lineage plasticity in both adult mouse and
human islets.4 These rare, pancreas-derived, multipotential progenitor (PMP) cells express insulin, albeit
at reduced proportions as compared to proto-typical
b-cells, and display b-progenitor characteristics, with
increased expression of Nkx6.1, Pdx1, and Ngn3, and
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importantly, a lack of Glut2. 5 These PMPs were identiﬁed after culturing dispersed islets in clonal sphereforming conditions, generating rare PMP sphere
colonies which displayed features of both neural and
pancreatic precursors.4,5
In the embryo, pancreatic b-cells develop from
bipotent trunk cells in the ductal epithelium and
therefore share a common precursor population with
duct cells. 6 Islets have been demonstrated to undergo
an apparent dedifferentiation in vitro to an epithelial,
ductal phenotype as a model for b-cell plasticity.7–9
Dedifferentiation is deﬁned here as the loss of mature
and functional characteristics from a partially or terminally differentiated cell type, and which, in some
cases, may occur prior to trans-differentiation, or
the change from one differentiated phenotype to
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another.10,11 A minority compartment of b-cells
within islets which demonstrated the capacity for
dedifferentiation in vitro has been reported previously,
with 1.4%12 and 0.5%13 of b-cells dedifferentiating in
vitro from mouse, and <5% of human b-cells dedifferentiating in vitro using similar culture conditions,7
although none of these studies characterized the rare
plastic cells. These low rates of dedifferentiation might
indicate that only rare b-cells are capable of survival
and phenotypic transition, and potentially suggesting
b-cell heterogeneity. We have further examined the
potential role of postnatal PMP-like cells in the plasticity of b-cells using an in vitro approach. We
hypothesized that plasticity of b-cells would be greatest in early life and that postnatal day 7 (P7) would be
an optimal age to identify and study resident PMPlike cells. Our strategy was to use RIPCre;Z/APC/C
14,15
and RIPCre;ROSA-eYFPC/C transgenic mice
where the majority of b-cells are genetically tagged
with a human placental alkaline phosphatase (HPAP)
and enhanced yellow ﬂuorescent protein (eYFP)
reporters, respectively, to investigate and characterize
the identity, location, and fate of b-cells that demonstrate phenotypic plasticity.

Methods
Animals

All animal experimentation was approved by the
Western University Animal Use Ethics Committee, in
accordance with the Canadian Council on Animal
Care. Rat insulin promoter (RIP) CreC/C mice (B6.CgTg(Ins2-cre)25Mgn/J)14 (Jackson Laboratories, strain
3573) were crossed with a reporter mouse strain containing an ALPP/HPAP gene construct (CAG-Bgeo/
ALPP)1Lbe/J) (LacZ/HPAP)15 (Jackson Laboratories,
strain 3919). Genotyping of RIPCre;Z/APC/C mice
was accomplished by PCR ampliﬁcation using primers
for the RIPCre (FW - gcggtctggcagtaaaaactatc and
RV-gtgaaacagcattgctgtcactt, 100 bp) and Z/AP (FWccgcttcccatatgtggctctgtcc and RV – gcatgagctcagtgcggttccacac, 548bp) transgenes from P5 pups.
LacZ¡ littermates were used as controls. A second
reporter strain containing a yellow ﬂuorescent protein
gene construct (B6.129X1-Gt(ROSA)26Sortm1(EYFP)
Cos/J) (R26R- EYFP) were used to conﬁrm ﬁndings
(Jackson Laboratories, strain 6148).

Islet dedifferentiation

Reagents were obtained from Life Technologies unless
otherwise stated. Islets were isolated from P7 mice as
described,16,17 and cultured in dedifferentiation medium
containing DMEM/F-12 (Gibco,12400–024), 10% FBS
(12483020), 1 mg/mL insulin (Sigma Chemical, I0516),
100 ng/mL cholera toxin (Cedarlane Labs, 101B(LB)),
1 mM dexamethasone (Sigma, D4902), 0.1 mg/mL soybean trypsin inhibitor (Gibco, 17075–029), and 10 ng/
mL epidermal growth factor (EGF) (Sigma, E4127).7–9
Whole islets were plated 25/well in a 6-well plate
coated with 1 mL type I (rat-tail) collagen. All cell culture medium contained 100 mmol/L penicillin/streptomycin (15140–122) and 10 mmol/L fungizone (15290–
018) and was changed every 2–3 d.
Redifferentiation of dedifferentiated cells

After 1 week in ductal dedifferentiation culture, collagen
was digested using Collagenase XI (Sigma, C9263), and
the cell monolayer dispersed into single cell suspension
using Dispase (Corning, IWR-CACB354235) and Accutase (BD Biosciences, SCR005 (CH)). Cells were cultured
for endocrine redifferentiation in medium previously
shown to promote endocrine maturation as described by
Russ et al, 18 and similar to Seaberg et al, 4 consisting of
DMEM/F12, 25 mmol/L D-glucose, 1% bovine serum
albumin (BSA) (Sigma, A7906), insulin/transferring/selenium (ITS) (Sigma, I1884), N2 (17502–048) and B27
supplements (17504–044), 10 mmol/L nicotinamide
(Sigma, N0636), 8 nm exendin-4 (a kind gift from Dr.
Savita Dhanvantari, Lawson Health Research Institute),
and 8 nm activin-A (Cedarlane Labs, CL2950R-10), in 6well tissue culture plates coated with Matrigel (1:25 dilution) (BD Biosciences, 354234).
Fluorescent immunohistochemistry

Pancreata were ﬁxed in 4% (v/v) paraformaldehyde
(PFA) (Electron Microscopy Sciences, 15710–5) for 24 h,
washed in PBS for 24 h, and suffused in 30% sucrose
overnight prior to embedding in OCT (Tissue Tek, 4583)
and frozen at ¡80 C. Pancreata were sectioned at 8 nm.
Cultured cells were dispersed from monolayers and
afﬁxed to glass-bottom dishes (MatTek Corp, P35-0-14C)
pre-adsorbed with diluted Cell-Tak (BD Biosciences,
CACB354240), then ﬁxed with 4% PFA for 15 min and
stored in PBS. The rabbit HPAP antibody (Abcam)
required antigen retrieval at 95 C in 10 mmol/L sodium
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citrate for 20 min, and Ki67 required antigen retrieval
using 100 mmol/L Tris-EDTA at 100 C for 30 min. The
mouse HPAP antibody (Sigma) required a Mouse-onMouse immunostaining kit (Vector Laboratories, FMK2201). Isolated cells and pancreas sections were permeabilized with 0.3% triton-X-100/PBS for 10 min before
blocking with Background Sniper (Biocare Medical,
BS96614) for 8 min and washed. Primary antibodies
(Table 1) were incubated overnight at 4 C in Antibody
Diluent Solution (Dako, 79149). Secondary antibodies
were appropriately matched to the primary antibody and
tissue sections/cells incubated at RT for 2 h in the dark.
Mice were injected with 2 ml 10mmol/L EdU per gram
body weight 24 h prior to dissection, or, for in vitro incubation, 0.05% (v/v) was added to culture medium for 6 h
prior to ﬁxation, and stained with the EdU Click-It Reaction kit (C10340). Apoptosis was determined using an In
Situ Cell Death Detection kit (TUNEL) (Roche,
12156792910). DAPI (4, 6-diamidino-2 phenylindole,
dihydrochloride) (1/500, D1306) was used as a counterstain for cell identiﬁcation. MatTek dishes and slides
were imaged on a Zeiss LSM 510 Duo Vario confocal
microscope (Carl Zeiss Ltd, Oberkochen, Germany)
located at The Biotron (Western University), and
counted manually using LSM 5 software.
Quantiﬁcation of cells

HPAPC cells were quantiﬁed by co-staining with insulin in P7 pancreas sections (>250 insulinC cells/
Table 1. Antibodies used for immunoﬂuorescent histochemistry.
Protein
Insulin
Insulin
Insulin
Glut2
Glut2
Glucagon
Somatostatin
Ck19
Ck19
Ki67
HPAP
HPAP
GPM6a
GFAP
b-III tubulin
Amylase
GFP

Species

Company

Cat. No.

Dilution

mouse
rabbit
guinea pig
goat
rabbit
rabbit
mouse
mouse
rabbit
mouse
mouse
rabbit
mouse
rabbit
mouse
mouse
rabbit

Sigma Chemical
Santa Cruz
Abcam Inc.
Santa Cruz
Millipore EMD
Santa Cruz
Santa Cruz
Dako
Abcam
BD Biosciences
Sigma
Abcam
MBL International
Millipore
Sigma
Abcam
Abcam

I2018
sc-9168
ab7842
sc-7580(C-19)
07–1402
sc-13091
sc-25262
m0888
ab15463
550609
A2951
ab133602–3
D055–3
AB5804
T5076
sc12821
ab290

1:2000
1:200
1:300
1:100
1:500
1:200
1:200
1:100
1:100
1:50
1:500
1:200
1:100
1:200
1:500
1:50
1:300

Glut2: glucose transporter 2
CK19: cytokeratin19
HPAP: human placental alkaline phosphatase
GPM6a: glycoprotein m6a
GFAP: glial ﬁbrillary acidic protein
GFP: green ﬂuorescent protein.
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section). Isolated islets from each mouse were cultured
separately. At least 5 replicate cultures were performed,
with >2000 cells counted per time point/replicate. Due
to low reporter protein presence after culturing, all
HPAPC cells were counted per MatTek dish. At least
20 ﬁelds of view (FOV) were captured and total cell
numbers counted (>50 cells/FOV). The proportion of
HPAPC/total cells was calculated by extrapolating the
average number of cells/FOV, then projecting this
number to total FOV/dish.

Fluorescent activated cell sorting

Pancreata from P7 mice were perfused with 2 ml
digestion buffer (1.0 mg/ml collagenase V (C9263),
0.2 mg/ml BSA, 0.1 mg/ml soybean trypsin inhibitor,
in HBSS), pooled, and incubated at 37 C for 30 min in
a shaking water bath. Cells were washed and further
dispersed with 0.25% trypsin (25300054), shaken in a
37 C water bath for 5 min, then drawn twice through
14 G, 18 G, and 22 G needles. Enzymes were inactivated by the addition of 5 ml media, containing HBSS
(Sigma, H1387) C 10% FCS C 0.1 mg/ml DNase I
(18068–015). After washing, the resulting cells were
re-suspended in 1 ml Red Blood Cell Lysis Buffer
(Sigma, R7757) for 1 min, then inactivated by adding
5ml HBSS C 10% FCS C 0.1 mg/ml DNase I. Dissociated cells were ﬁltered through a 40 mm nylon mesh
(BD Biosciences, CA21008). Primary (GPm6a and
Glut2, Table 2) and secondary antibodies were incubated sequentially for 60 min each to label b-cells.
Seven-Aminoactinomycin D (7-AAD) (BD Pharminogen, 51-68981-E) was added as a viability marker.
Cells were sorted on a Becton Dickinson FACSAria III
cell sorter running FACSDiVa software (v 6.1.2) at the
Table 2. Primer sequences designed for the ampliﬁcation of
mouse cDNA by qPCR.
Gene
Insulin
Pdx1
Glut2
Ngn3
Nkx6.1
MafB
CycloA

Sense primer (50 -30 )
agccccggggaccttcagac
gttggatagccggagagatg
acaccggaatgttcttagcc
ggcgcctcatcccttggatg
tctggctgtgggatgttagc
ggtataaacgcgtccagcag
atggtcaaccccaccgtgt

Antisense Primer (50 -30 ) Band Size (bp)
gcgggtcgaggtgggcctta
agtttggagcccaggttg
gtgagagaagccgaggaaag
cagtcacccacttctgcttcg
tcatctcggccatactgtgc
cgagtttctcgcacttgacc
ttctgctgtctttggaactttgtc

134
151
109
161
106
138
102

Pdx1: pancreatic duodenal homeodomain box 1
Glut2: glucose transporter 2
Ngn3: neurogenin3
MafA: V-maf musculoaponeurotic ﬁbrosarcoma oncogene homolog A
Nkx6.1: homeobox protein Nkx_6.1
Cyclo A: Cyclophilin A.
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London Regional Flow Cytometry Facility at Robarts
Research Institute at Western University (London,
Ontario). Gating strategy is shown in supplemental
Figure S1.
Glucose-stimulated insulin secretion (GSIS)

Cells recovered from ﬂow cytometric sorting were cultured overnight in DMEM/F-12 C 10% FBS, or dedifferentiated and redifferentiated in vitro, and stimulated
as described for static GSIS assays using 2.8 and
16.7 mmol/L D-glucose.19 Insulin release was determined using an Ultrasensitive Insulin RIA (range 0.02–
1 ng/ml) (St Joseph Health Care, London Canada).
Neural-lineage differentiation

InsC(GPm6aC or YFPC)Glut2HI/LO cells recovered
after sorting were cultured in Neurocult Neural Stem
Cell (NSC) Basal Media (StemCell Technologies, Inc.
Inc., 5700) with Proliferation Supplement (StemCell
Technologies, Inc., 5702) plus EGF and basic ﬁbroblast growth factor (bFGF) (PHG0266) as per manufacturer’s instructions on low attachment plates
(Corning, 29446-3-030) for 7–14 d. Intact neurospheres were transferred to Matrigel-coated (1/25)
MatTek dishes, and cultured with NSC Basal Media
with Differentiation Supplement (StemCell Technologies, Inc. Inc., 5703) for 7–14 d.
Quantitative PCR

Total RNA (1 mg) from isolated P7 islets (n D 5) or
neurospheres produced by GFPCGlut2LO cells recovered from ﬂow cytometry (n D 4) was extracted using
RNeasy Plus Micro kits (Qiagen, 74034) and Qiashredders (Qiagen, 79564). RNA was reverse transcribed
using iScript Reverse Transcription Supermix (BioRad Laboratories, 170–8840). Quantitative PCR
experiments were performed using the 2-DDCT method
after conﬁrmation of parallel PCR ampliﬁcation efﬁciencies on a Real-Time PCR ABI Prism 7500. IQ
SYBR Green (Bio-Rad, 170–8882) was employed for
detection of PCR products, using primer sequences
provided in Table 2. PCR reactions were run in duplicate using an initial denaturation at 95 C for 5 min,
followed by cycles of denaturation (95 C for 15 sec),
primer annealing (60 C for 1 min) and transcript
extension (50 C for 2 min) for 40 cycles.

Statistical analysis

Data are expressed as mean § SEM, and comparisons
between groups analyzed using a Student’s t-test or
one-way ANOVA with a minimum acceptable level of
signiﬁcance of p < 0.05. Statistical analysis was performed using GraphPad Prism software (v. 5.01, La
Jolla, CA).

Results
Loss of islet phenotype after culture

Freshly isolated Islets from 7-day old mice lost their 3dimensional architecture within 1 week of culturing in
epithelial-cell promoting/dedifferentiation conditions,
forming a rapidly expanding monolayer which could
be maintained for up to 4 weeks (Figs. 1A-C).
Intact islets did not demonstrate immunostaining
for the ductal marker cytokeratin-19 (Ck19) (Fig. 1D,
white bar). After 1 week in dedifferentiation medium,
74.7 § 3.8% of cells present expressed Ck19 (hatched
bar, p < 0.001), and this phenotype was maintained
throughout the remaining culture period (4 weeks,
black bar). In freshly isolated islets, 5.3 § 0.8% of cells
were shown to be undergoing proliferation by EdU
localization (total EdUC/total DAPIC) (Fig. 1E, white
bar). After islet dedifferentiation culture for 1 week,
this increased to 33.1 § 8.2% (hatched bar, p <
0.001); but dropped thereafter to 10.8 § 3.7% (black
bar, p < 0.01), revealing the generation of a new proliferative, epithelial cell monolayer which expressed a
ductal marker. Immunostaining for the acinar cell
marker amylase (Fig. S2A, green) was seen in pancreas
sections outside of the islet (Fig. S2A, insulin, red),
and was absent after 1 week in the dedifferentiated cell
monolayer (Fig. S2B), as was insulin.
Lineage tracing illustrates rare b-cell
dedifferentiation

We sought to determine the extent to which speciﬁcally
b-cells contributed to islet cell dedifferentiation in vitro
using the HPAP lineage tracer localized by immunohistochemistry of P7 RIPCre;Z/APC/C mice. Insulinexpressing b-cells (Fig. 2A, green) were identiﬁed by
the HPAP reporter protein (Fig. 2A, red) within islets
in situ with an efﬁciency of 85.3 § 1.2% (Fig. 2A,
merged, and C, white bar). The staining frequency of
HPAP in extra-islet b-cell clusters containing <5
b-cells was signiﬁcantly lower at 39.0 § 6.9% (p <
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Figure 1. In vitro dedifferentiation of neonatal mouse islets. Photomicrographs depicting neonatal (P7) mouse islets immediately following isolation (A), 4 d after plating on collagen under dedifferentiation culture conditions (B), and after 1–4 weeks in vitro (C). The total
proportion of cytokeratin-19 (Ck19C)-expressing cells signiﬁcantly increased after islets (D, white bar) were cultured in ductal epithelial
promoting conditions (D, hatched bar D 1 week; black bar D 4 weeks) and which was maintained. The cell proliferation index (total
EdUC/DAPIC cells, E) increased after islets (E, white bars) were cultured for ductal dedifferentiation for 1 week (E, hatched bar), and
decreased thereafter (E, black bar, 4 weeks). Size bars denote 50 mm, n > 10 experiments, data are represented as % mean § SEM, p
< 0.01,  p < 0.001.

0.01) (Fig. 2B, arrows, and C, black bar). Within tissue
sections, b-cells constituted 78.9 § 4.4% of total islet
cells; thus, given the labeling efﬁciency, 67.3 § 0.9% of
total islet cells expressed HPAP before isolation and
culture. Pancreas sections from P7 RIPCre;Z/AP¡/¡
control littermates did not exhibit HPAP immunostaining (Fig. S3A, insulin, green; HPAP, red). Ck19expressing cells were identiﬁed around ducts (Fig. S3B,
red) but not within HPAPC islets (Fig. S3B, green) in
P7 RIPCre;Z/APC/C pancreas sections. The extra-islet
endocrine cell clusters were not included in the following whole islet analysis due to the physical limitations
of handpicking these structures.
After islet isolation and in vitro culture, there was a
progressive loss of insulin-immunoreactive cells over
1 week (Fig. 2D, red), and the frequency of HPAP
expression dropped signiﬁcantly to <0.2% of cells
present in the ductal epithelial monolayer (Fig. 2D,
green, 67.3 § 0.9% vs 0.14 § 0.03% HPAPC/total cells,
p < 0.0001, islet vs 1 week). This represented 14–95
immunostained HPAPC cells retained per MatTek
dish. Of the surviving HPAPC cells that no longer

exhibited immunoreactive insulin (Fig. 2E, HPAP,
green), 87.5 § 3.9% demonstrated expression of Ck19
(Fig. 2E, red) (islet vs 1 week, p < 0.0001) which was
maintained during longer cultures. Analysis of the
proliferation rate of these remaining HPAP-tagged
cells by dual staining with EdU showed a signiﬁcant
increase after 1 week of culture compared to freshly
isolated islets (Fig. 2F, 3.5 § 0.2% isolated islets (white
bar) vs. 25.6 § 1.8% 1 week in vitro (hatched bar), p <
0.001), but decreased thereafter (Fig. 2F, black bar,
4 weeks). Visualization of apoptosis showed that a
major loss of insulin-immunoreactive cells occurred
after 5 d of culture (Fig. 2G, insulin, green; TUNEL,
red). Due to the nature of the reporter protein, which
tracks the b-cell directly and not insulin production,
these results indicate that a minority of b-cells survived in vitro with a higher proliferation rate than islet
b-cells in situ, but demonstrated a phenotypic change
with a loss of insulin and the expression of the ductalepithelial cell marker Ck19, suggesting a dedifferentiation process. Subsequent re-culture of these remaining
HPAP-expressing cells in media previously shown to
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Figure 2. Speciﬁcity of HPAP to the b-cell using RIPCre;Z/APC/C mice and lineage tracing of the b-cell during in vitro islet dedifferentiation. RIPCre;Z/APC/C transgenic mouse model showing insulinC b-cells (green, A) tracked by the reporter protein HPAP (red, A), and
quantiﬁed in (C). The proportion of insulin-expressing b-cells (B, green) co-labeled by HPAP (B, red) in b-cell clusters containing fewer
than 5 b-cells was signiﬁcantly lower than in islets (B, C, black bar). After islets were cultured in dedifferentiation media for 1 week, all
insulin expression was lost (D, red), and only a minority of cells retained HPAP expression (D, green). The majority of cells present in culture after 1 week immunostained for Ck19 (E, red), as did the rare remaining HPAPC cells (green). These HPAPCCk19C were proliferative
at 1 week in culture (F, hatched bar) but proliferation decreased thereafter (F, 4 weeks, black bar). There was a signiﬁcant increase in
b-cell apoptosis after 5 d in dedifferentiation conditions (G, insulin, green; TUNEL, red). After replating the resultant epithelial-like monolayer of cells in redifferentiation medium, the majority of the rare, remaining HPAPC cells (H, green) re-expressed insulin (H, red). Scale
bar denotes 50 mm, n > 6, data are represented as % mean § SEM, p < 0.01,  p < 0.001.
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promote endocrine redifferentiation18 revealed that
greater than 90% of these cells expressed insulin over
4 weeks of culture (Fig. 2H, insulin, red; HPAP, green)
demonstrating substantial phenotypic plasticity. We
next examined the deﬁning characteristics of this subpopulation of b-cells.

Characterization of b-cell subpopulations by Glut2
and GPM6a presence

We examined whether the subpopulation of HPAPC
tagged b-cells that survived tissue culture and had an
apparent phenotypic plasticity were comparable to the
previously reported rare, pancreas-derived multipotential progenitor (PMP) cells in mouse pancreas.5
Distinguishing characteristics of these PMP cells were
their reduced, but detectable expression of insulin
while having extremely low or absent expression of
the glucose transporter-2 (Glut2), and the expression
of transcription factors normally associated with
endocrine pancreas development during organogenesis.5 As the proportion of these progenitor cells in
islets was reported to be only 1–5/10,000,5 ﬂow cytometric sorting of b-cells from RIPCre;Z/APC/C dispersed whole mouse pancreata was initially used to
optimize yield. Cells were immunostained using antibodies for GPM6a,20 a cell surface marker shown to
speciﬁcally identify the b-cell, and differentially sorted
for the presence of Glut2. GPM6a (red) immunostained, insulin-expressing (green) b-cells are shown in
Figure 3A. Flow cytometry demonstrated that
GPM6a-expressing b-cells were sorted into 3 fractions: GPM6aHIGlut2HI cells (Fig. 3B, red, representing typical b-cells) and GPM6aCGlut2MID/LO cells
(Fig. 3B, green); further split arbitrarily into GPM6aCGlut2MID and GPM6aCGlut2LO fractions and collected
separately. At P7, GPM6aCGlut2LO cells represented
0.9 § 0.2% of all live cells sorted from whole pancreas,
compared with 0.4 § 0.2% of cells identiﬁed as
GPM6aCGlut2MID and 1.0 § 0.2% possessing a
GPM6aCGlut2HI phenotype (Fig. 3B, nD12 sorts).
Insulin immunostaining was more prominent in the
GPM6aCGlut2HI cells than in the other populations
(Fig. 3C, red). GPM6aCGlut2HI b-cells were immunopositive for Glut2 (Fig. 3C, green, top panel), but this
was greatly diminished in the GPM6aCGlut2MID cells
(middle panel), and absent in the GPM6aCGlut2LO
cells (lower panel). These data indicate that neonatal
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mouse b-cells exist within a spectrum of Glut2
presence.
These cell populations were recovered after cell
sorting and cultured in the presence of 16.7 mmol/L
D-glucose for 75 min prior to measurement of
secreted insulin. As expected, GPM6aCGlut2HI cells
readily secreted insulin (18.6 § 1.8 ng), whereas insulin secretion from the same number of GPM6aCGlut2LO cells was not detected (<0.02 ng),
demonstrating that the GPM6aCGlut2LO cells were
functionally unresponsive to glucose (nD3, 6000
sorted cells/experiment).
When cultured in dedifferentiation media conditions, the majority of GPM6aHIGlut2HI b-cells did
not survive (not shown), similar to unsorted, isletderived b-cells. Conversely, GPM6aCGlut2MID/LO
cells survived in vitro, retained the HPAP b-cell
tag, lost insulin immunoreactivity, and immunostained for Ck19 (Fig. 3D, arrows, Ck19 (red),
HPAP (green)). These GPM6aCGlut2LO cells exhibiteda »2-fold higher proportion of Ck19C cells
after 4 weeks dedifferentiation than did the
GPM6aCGlut2MID cells (72.4 § 7.7% of Glut2LO vs
42.7 § 8.9% of Glut2MID cells, p < 0.01, n D 5),
possibly suggesting that the GPM6aCGlut2MID cells
represent a transition state between Glut2LO and
Glut2HI. When these dedifferentiated cells were
subsequently cultured in redifferentiation medium,
HPAPC cells (Fig. 3E, green) derived from
GPM6aCGlut2LO cells displayed insulin expression
(red). However, under these conditions the resulting cells released considerably less insulin than did
freshly separated GPM6aCGlut2HI b-cells (above)
in a low or high glucose environment (2.8 mmol/L,
14.1 § 0.4 pg, and 16.7 mmol/L glucose, 18.9 §
0.4 pg insulin/5£104 cells, n D 3). These results
are consistent with the magnitude of insulin release
observed from de novo b-cells generated from
human stem cells21 that demonstrated an immature
phenotype in vitro. Moreover, glucose responsiveness may be only obtained after in vivo transplantation and maturation.4,22
To conﬁrm the above ﬁndings using RIPCre;Z/APC/
C
mice sorted by GPM6a, we utilized a separate
ROSA-eYFP reporter strain to label b-cell progeny
(RIPCre;ROSA-eYFPC/C mice). Figure 4A demonstrates YFP (GFP, green) labeling of b-cells (insulin,
red) within P7 pancreas sections. Flow-cytometric sorting of RIPCre;ROSA-eYFPC/C P7 mouse pancreas by

72

C. A. BEAMISH ET AL.

Figure 3. Pancreatic b-cells sorted by ﬂow-cytometry using Glut2 and GPM6a presence. Insulin-expressing b-cells (A, green) could be identiﬁed
by GPM6a (A, red) using immunoﬂuorescence. Whole mouse P7 pancreas (B, left) was dispersed and sorted into distinct populations of insulinC
(GPM6aC) cells according to differential Glut2 expression: GPM6aCGlut2C (B, red) and GPM6aC Glut2MID/LO(green), further split into GPM6aCGlut2LO (B, green) and GPM6aCGlut2MID (B, left, darker green, upper). Cells recovered after sorting (C) were immunostained for Glut2 (green) and
insulin (red). Insulin staining (C, red) was more prominent in proto-typical b-cells (GPM6aCGlut2HI, top panel) as compared to GPM6aCGlut2MID/
LO
cells. Glut2 immunostaining (C, green) was diminished in the GPM6aCGlut2MIDcells (C, middle), and was absent in the GPM6aCGlut2LO cells (C,
green, bottom). After ﬂow cytometry, cell recovery, and 1 week in dedifferentiation culture, the majority of InsCGlut2LO cells co-expressed Ck19
(red) and HPAP (green) (D, arrows and circle). Redifferentiation of dedifferentiated ductal-like cells after 4 weeks in culture demonstrated the
b-cell lineage reporter HPAP (E, green) co-localizing with insulin (E, red, arrow). Scale bar denotes 50 mm, n D 5.
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Figure 4. Conﬁrmation of the b-cell origin of GPM6aCGlut2LO cells using the reporter strain ROSA-eYFP. (A) insulin (red) and GFP
(green) immunostained b-cells are shown within RIPCre;ROSA-eYFPC/C P7 mouse pancreas sections (n D 5). After sorting live cells by
ﬂow cytometry from whole pancreas using GFP and Glut2, the GFPCGlut2LO cells dedifferentiated in vitro to ductal-lineage cells (B,
Ck19, red and GFP, green, n D 4). These cells were able to redifferentiate back into insulin-expressing cells in vitro (C, insulin, red;
GFP, green, n D 4).

Glut2 and GFP expression yielded similar proportions
of cells as previously found using RIPCre;Z/AP mice,
with GFPCGlut2LO cells representing 0.8§0.3% of total
live cells from whole pancreas, compared with 2.6§
0.7% of cells being GFPCGlut2HI. Once placed in ductal
dedifferentiation media, GFPCGlut2LO cells similarly
lost insulin immunoreactivity and dedifferentiated into
GFPCCk19C cells (Fig. 4B, GFP (green) and Ck19
(red)), whereas GFPCGlut2HI cells did not dedifferentiate (not shown). Dedifferentiated GFPCCk19C cells
were then able to redifferentiate back into insulinexpressing cells (Fig. 4C, GFP (green) and insulin
(red)). Therefore results were consistent using 2 different b-cell lineage reporters.
InsCGlut2LO cells generate neurospheres and neurallineage cells in vitro

To assess their cellular plasticity, GPM6aCGlut2LO
cells from RIPCre;Z/APC/C mice were recovered after
FACS and cultured in neural proliferation conditions.
A subset (~1/200) of these GPM6aCGlut2LO cells proliferated and formed neurospheres (Fig. 5A), while

GPM6aCGlut2HI cells did not proliferate (Fig. 5B).
After subsequent neural differentiation culture, the
GPM6aCGlut2LO-derived neurospheres formed cells
with neuronal-like processes (Figs. 5C, D), and demonstrated immunostaining for the neuronal marker
b-III tubulin (Fig. 5E, green) and the astrocyte marker
glial ﬁbrillary acidic protein (GFAP) (Fig. 5F, red).
Both of these resulting cell phenotypes expressed the
b-cell marker HPAP (Fig. 5E, red, and Fig. 5F, green),
indicating a lineage plasticity of GPM6aCGlut2LO cells
such that all neurospheres generated both neuronal
and astrocytic cell types.
Neurospheres were similarly generated after in vitro
culture of GFPCGlut2LO cells isolated from RIPCre;
ROSA-eYFPC/C mice. These neurospheres expressed
YFP (GFP, green) and insulin (red) as shown in
Figure 5G, indicating their b-cell origin. Neurospheres
demonstrated a gene expression proﬁle consistent
with immature b-cells, showing decreased expression
of Ins and Glut2, and an increased expression of MafB
and Ngn3, when compared to isolated P7 islets by
qPCR (Fig. 5H, p < 0.05). While there was a trend
toward increased expression of Pdx1 and Nkx6.1 in
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Figure 5. Lineage plasticity of pancreatic Glut2LO b-cells. GPM6aC cells recovered from whole mouse RIPCre;Z/APC/C P7 pancreas after
ﬂow cytometry and cell sorting based on Glut2 presence were placed in neural proliferation conditions. Neurospheres (A) were generated from GPM6aCGlut2LO cells, compared to non-proliferative GPM6aCGlut2HI cells (B). After culture in neural differentiation conditions, the neurospheres generated multiple morphologies, including neuron-like processes (C, D). When subjected to
immunoﬂuorescent staining, cells with a neuronal appearance were visualized by b-III tubulin (E, green), and astrocytes by GFAP (F,
red). These neural-lineage cells co-stained with HPAP (red, E; green, F; n D 5). Neurospheres (G, GFP, green, and insulin, red) were similarly generated from sorted GFPCGlut2LO b-cells derived from RIPCre;ROSA-eYFPC/C P7 pancreas, when cultured under neural proliferation conditions, and demonstrated an immature b-cell phenotype by quantitative PCR with decreased expression of Ins and Glut2, and
increased expression of Ngn3 and MafB (H, p < 0.05, neurospheres vs P7 islets, n D 4). Scale bar denotes 100 mm (A, B), 50 mm (C-G).
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the neurospheres, high variability between samples
resulted in no signiﬁcant change when compared to
neonatal islets.
InsCGlut2LO cells are primarily found outside of islets

Flow cytometric sorting was performed on b-cells
recovered from isolated RIPCre;Z/APC/C mouse islets
as opposed to whole pancreas to separate GPM6aCGlut2HI, GPM6aCGlut2MID, and GPM6aCGlut2LO
cells. In contrast to whole pancreas, GPM6aCGlut2MID
cells could not be recovered from isolated islets, and
the population of GPM6aCGlut2LO cells represented
only 0.3 § 0.1% of total live cells (Fig. 6A, green) compared with 54.0 § 4.8% of cells being GPM6aCGlut2HI
(red). Thus, the abundance of GPM6aCGlut2LO cells
was 3 times lower in islets than in whole pancreas,
suggesting a predominantly extra-islet localization.
To identify the anatomical location of the insulinimmunoreactive, but Glut2-low/negative cells, mouse
pancreas sections were examined. While some
InsCGlut2LO cells were located in islets (Fig. S4, insulin, red; Glut2, green, arrow indicates an InsCGlut2LO
cell), the majority of these cells were located outside of
islets in small b-cell clusters (1–5 b-cells), with many
of these cells also undergoing proliferation. A representative InsCGlut2LOEdUC cell is shown in
Figure 6B. When quantiﬁed, InsCGlut2LO cells represented 3.5 § 0.2% of all insulin-expressing b-cells in
the P7 mouse pancreas by ﬂuorescent immunocytochemistry (Fig. 6C, 1935 cells, nD5 pancreata). When
stratiﬁed by b-cell location, InsCGlut2LO cells represented 1.2 § 0.3% of insulinC cells within islets (>6
b-cells), but 20.5 § 3.6% of insulinC cells within
extra-islet b-cell clusters (<5 b-cells, clusters)
(Fig. 6C, 23/1703 cells and 45/232 cells, respectively).
Furthermore, the proliferation rate of insulinC cells
was higher in b-cell clusters than in islets at P7 by
EdU presence (Fig. 6D, 12.6 § 0.7% vs 2.8 § 0.2%
respectively). When further sub-analyzed by phenotype, 12.8 § 4.1% of InsCEdUC cells lacked Glut2
within islets, and 20.1 § 5.6% within clusters
(Fig. 6E), illustrating that at P7 InsCGlut2LO cells are
proliferative both within and outside of the islet as
compared to InsCGlut2HI b-cells.
It is possible that the sub-population of
InsCGlut2LO b-cells in P7 mouse pancreas represents
an immature population only present in early postnatal life. We therefore quantiﬁed their presence in adult
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mouse pancreas (3 months age) using immunostaining for insulin, Glut2, and Ki67. In adults, the proportion of insulin-expressing b-cells found in extra-islet
clusters was signiﬁcantly lower than at P7 (Fig. 6F,
15.5 § 1.8% vs 5.3 § 1.7%, 7 d vs 3 mo,  p < 0.01),
demonstrating that most b-cells are located within
proto-typical islets during adult life. The b-cell subpopulation of interest, InsCGlut2LO cells were still
present in adult pancreas, although their abundance
was also lower than in the neonate (Fig. 6G, 3.5 §
0.2% vs 0.8 § 0.2%, 7 d vs 3 mo,  p < 0.01), coinciding with a decrease in cluster proportion and illustrating endocrine pancreas maturation to a functional
phenotype. A similar age-related change was found in
total b-cell proliferation following immunostaining
for insulin and Ki67 (Fig. 6H, 6.1 § 0.8% vs 0.8 §
0.1%, 7 d vs 3 mo,  p < 0.001). These data provide
strong evidence for a substantial proportion of
InsCGlut2LO cells predominantly present within extraislet endocrine cell clusters in the young mouse and
decreasing with age.
HPAPC cells tag non-insulin-expressing cells with
advancing age

In the neonatal RIPCre/Z/APC/C mouse (<14 d),
HPAPC cells that immunostained for glucagon (Gcg)
or somatostatin (Sst) were extremely rare (Fig. 7A and
B, white bars), whether quantiﬁed by proportion of
marker/HPAP (A) or HPAP/marker (B). However,
when older (>1 y) RIPCre;Z/APC/C mice were examined, the proportion of HPAP-labeled cells (green)
that also immunostained for glucagon (Fig. 7A and B,
black bars, and C, red) or somatostatin (Fig. 7A and B,
black bars, and D, red) increased. These results indicate that some of the HPAP-tagged cells demonstrate
a trans-lineage endocrine fate as mice age.

Discussion
In agreement with previous reports, we show here that
rare b-cells, tracked by HPAP or GFP reporter protein
expression, demonstrate the capacity for dedifferentiation to a hormone-negative, ductal-epithelial-like phenotype expressing Ck19.8,9 We hypothesized that
these cultured, reporter-labeled, Ck19-expressing and
insulin-negative cells represented the progeny of
InsCGlut2LO cells, reported to denote a pancreatic
multipotent progenitor (PMP) cell pool.5 We have
shown that these PMP-like cells can be isolated from
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Figure 6. InsCGlut2LO b-cells are primarily found outside of islets. FAC-sorted GPM6aCGlut2LO cells isolated from P7 islets represented
0.3 § 0.1% of live cells (A), a lower proportion relative to that found in whole pancreas (see Fig. 3B). (B) Mouse P7 pancreas section
immunostained for insulin (i, red), Glut2 (ii, green), EdU (iii, yellow), and merged images (iv), demonstrating an InsCGlut2LOEdUC cell
(arrow) located in an extra-islet b-cell cluster. Quantiﬁcation of InsCGlut2LO cells by b-cell grouping indicated their primary location in
clusters as compared to islets (C, p < 0.001 cluster vs total and islet). The proliferation rate of InsC cells at P7 was higher in extra-islet
clusters than in islets (D, p < 0.01), and there was a high occurrence of InsCGlut2LO cell proliferation within islets and clusters at P7 (E,

p < 0.01). The proportions of total extra-islet, insulin-expressing clusters (F, p < 0.01), total InsCGlut2LO cells (G, p < 0.01), and
total b-cell proliferation by Ki67 (H, p < 0.001) all decreased from 7 d to 3 months of age in the mouse. Scale bar denotes 50 mm, n
> 5. Data are represented as % mean § SEM.
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Figure 7. Alternate cell fates of HPAPC cells in vivo. HPAPC cells from RIPCre/Z/APC/C neonatal (<14 d, n D 5) mouse pancreas sections
rarely immunostained for non-insulin markers, including glucagon (Gcg) or somatostatin (Sst) (Fig. 7A and B, white bars) whether quantiﬁed by proportion of marker/HPAP (A) or HPAP/marker (B). In mice older than 1 y (n D 4), the proportion of HPAPC (green) labeled
non-insulin-expressing cells increased, including those containing glucagon (Fig. 7A and B, black bars, and C, red) or somatostatin
(Fig. 7A and B, black bars, and D, red) as compared to young mice. Arrows indicate dual stained cells. Scale bar denotes 50 mm. Data
are represented as % mean § SEM, C and D, >1 y vs <14 d, t-test,  p < 0.05,  p < 0.01.

neonatal mouse pancreas, and are capable of differentiation to a variety of cell types in vitro. Importantly,
while InsCGlut2LO cells can be found in intact islets as
reported,5 the majority are located in small, extra-islet
endocrine cell clusters, where they have a signiﬁcantly
greater proliferative capacity at P7 than do the
InsCGlut2HI cells. These ﬁndings add potential physiological relevance to the initial observations of van der
Kooy et al,4,5 indicating that there are multipotent
cells within the pancreas which express insulin and
persist into adulthood.
The proportion of total lineage-plastic cells shown
here in the neonate is higher than the reported rate in
adult mouse as found by Smukler and colleagues;5
however our approaches were different. Smukler
et al.5 used a clonal sphere assay to identify single
multi-potential b-cells within dispersed islets. From
this, the authors were able to ascertain that these cells
demonstrated low or absent Glut2 expression. We
have used this reduced/absent Glut2 expression as a
tool to identify and segregate subsets of b-cells, and
found that there is a relatively higher population of
such cells in the young mouse pancreas. We also

found that only a subset (1/200) of these InsCGlut2LO
cells are indeed multipotent under the neural culture
conditions used. Since 0.3% of live cells in islets represent GPm6a-immunostained Glut2LO b-cells, the
number of resident multipotent cells would be
approximately 1 in 1500 b-cells within islets. However, we have shown that the richest anatomical location of GPM6aCGlut2LO cells capable of proliferating
and forming neurospheres is not islets but the abundant small extra-islet endocrine cell clusters, which
were not examined in the former analysis. The presence of InsCGlut2LO cells persists into adult life,
although with a reduced abundance relative to neonates. This is due, in part, to a reduction in the number of extra-islet endocrine cell clusters with age.
Pancreatic endocrine cell and duct cell dedifferentiation or trans-differentiation have emerged as veriﬁed modes of cell plasticity in vivo, at times acting
in an attempt to maintain b-cell mass, but also perhaps an erroneous fate decision made by the cell
during stress. Expansive reviews showing the depth
of evidence were recently published by Weir et al.23
and Puri et al.10 As an Illustration, rare b-cells were
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shown to trans-differentiate to a-cells during type 2
diabetes progression,24 further confounding the loss
of b-cell mass, and representing b-cell failure.25 In
another study, b-cells lost insulin expression after
partial pancreatectomy, becoming proliferative,
Smad-7C cells, and adopting a pancreatic polypeptide (PP) identity, similarly representing a dedifferentiation step during injury.26 Endocrine cell transdifferentiation was shown in a type 1 diabetes
model, with autoimmunity furthering the loss of
b-cell mass in a trans- lineage progression from ato b- to d- cell phenotypes, ultimately resulting in
an excess of d- cells.27 It was recently shown that
b-cell dedifferentiation state may be assessed using
the presence of Urocortin 3 (Ucn3) as a marker of
b-cell maturity,19,28 and this dedifferentiated (nonfunctional) phenotype could be rescued by the addition of Alk5, which acted through the inhibition of
TGFb receptor 1 signaling.29 This ﬁnding supports
the concept that endocrine cell dedifferentiation can
be reversible.
The notion that progenitor cells may paradoxically
express mature markers, such as insulin, could explain
why such cells in the pancreas have remained elusive.
Interestingly, it does satisfy the evidence that postnatal
b-cells arise from pre-existing b-cells,1 but, as shown
here, not all insulin-expressing cells are of equivalent
phenotype. Other precedents exist for mature marker
presence in stem cell populations, such as neural stem
cells expressing the astrocyte marker GFAP.30 We
have shown that InsCGlut2LO cells represent 1.2% of
b-cells in the neonatal islet by immunostaining, but
only a subset of these cells are capable of differentiation to pancreatic islet and ductal phenotypes; the proportion of plastic cells still being higher than that
found by Smukler et al.5 However, a striking 3.5% of
insulin-expressing cells within whole pancreas at P7
lacked Glut2, and up to 21% of these cells are found
within clusters. This suggests that the highest source
of b-cells demonstrating lineage plasticity is found
outside of the islet, and these extra-islet clusters are
most abundant in the neonatal period and thereafter
decline with advancing age.31 The absence of Glut2
expression is likely not the sole identiﬁer of a progenitor for a b-cell however, since the co-expression of
other markers such as Ngn3 and Nkx6.1 has been proposed.5,32 Reports have demonstrated the presence of
putative b-cell progenitors during adulthood, with or
without diabetes, and showed that these cells exhibited

higher expression levels of Pdx1 and MafB, and low/
absent expression levels of genes indicative of mature
gene function, including Nkx6.1 and Glut2.33,34 Furthermore, these b-cells could be subdivided into those
with the ability to transition to mature b-cells in culture, and those that maintained a progenitor phenotype throughout, illustrating b-cell heterogeneity and
differing states of functional maturity.34
Beta cell heterogeneity is a burgeoning concept,
with our data contributing multiple ways to stratify
the b-cell: by age (neonatal vs adult); by location (islet
vs cluster); and by expression of transporters or transcription factors (Glut2, MafB, Ngn3), all of which
may confer degrees of function. These data support
evidence from others indicating b-cell heterogeneity
in relation to proximity to other cell types, vasculature,
and innervation patterns.35 Neonatal b-cells have been
shown to require a glucose threshold for maturation,
and b-cells from extra-islet clusters in young mice
are functionally altered than those within islets,
including differential expression of the peptide hormone Ucn3.19 It is well established that mouse b-cells
in the immediate postnatal period are immature, with
poor GSIS and lower expression of Glut2 compared to
adult b-cells.36–38 Furthermore, human infant b-cells
demonstrate some plasticity in insulin secretory
machinery.39 Indeed, one recent study showed tripotent progenitor cells present in P7 mouse pancreas,
generating endocrine, exocrine, and ductal lineages
dependent on in vitro conditions,40 but did not deﬁne
the cells capable of cellular plasticity. Our data suggests that a lack of Glut2 expression may reﬂect not
only b-cells with decreased function, but also a subset
of potential progenitor cells. Interestingly, StolovichRain et al. showed that after selective b-cell ablation
using doxycycline-mediated diphtheria toxin, surviving b-cells in the mouse pancreas displayed signiﬁcantly decreased levels of Glut2, purportedly due to
glucose toxicity.41 While injury models were not
examined in the present study, it must be assessed
whether a decrease in Glut2 expression is a necessary
mechanism during regeneration, a direct result of
environmental toxicity, or whether the surviving cells
exhibited Glut2 expression at all. As we have shown a
higher proliferation rate in situ in the InsCGlut2LO
cells, it is conceivable that these could clonally expand
in an attempt to replace b-cells after injury, with subsequent maturation to functional b-cells exhibiting
high Glut2 expression. Indeed, this was recently
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shown in a follow-up report from Razavi et al., showing a selective survival, proliferation, and differentiation potential of insulinCGlut2low cells toward a b-cell
phenotype after diabetes presence in both human and
mouse. 42
Russ et al. suggested that human b-cells were able to
dedifferentiate much more readily than mouse b-cells
in vitro.12 Despite distinctions between human and
rodent islets with respect to architecture43 and higher
prevalence of GLUT1 utilization over GLUT2,44–48
Smukler et al. demonstrated that InsCGlut2LO cells
from human islets had a similar phenotype, occurrence,
and lineage plasticity to those found in mice.5 Moreover, GLUT2 has been recently implicated in human
neonatal diabetes49 and its importance for glucose
transport into human b-cells has been demonstrated.50
If InsCGLUT2LO cells are as abundant in the small
endocrine clusters of human pancreas from young
donors as we have shown here in mice, the inclusion of
these cells may enhance the effectiveness and longevity
of human islet transplants.
Dor et al. showed that b-cells within extra-islet
clusters had a similar labeling index with a genetic
lineage tag as did those in larger islets, and concluded
that these represented small islets, or islets with b-cells
undergoing apoptosis, rather than reﬂecting a new
source of b-cells derived from a population with progenitor capabilities.1 Our experiments differ in that; 1)
we used a non-inducible transgenic model which
results in the labeling of a much higher percentage of
b-cells allowing for greater discrimination in sub-population changes, and 2) we studied neonatal as
opposed to adult mice. Within this paradigm, we have
shown that there is signiﬁcantly lower lineage labeling
with HPAP in b-cells located within b-cell clusters
than in anatomically mature islets in P7 mice (39%
versus 85%), which is likely to reﬂect the generation of
new b-cells from progenitors within the clusters during early postnatal life. While the number of extra-islet
clusters decreases with age in rodents, they are still
found in adulthood.31 Chintinne et al. found that the
majority of b-cells in young rats were present in small
aggregates (<50 mm diameter, including single cells)
which formed postnatally, and concluded that the
neogenesis and clustering of these aggregates is a key
process to attaining b-cell mass in adulthood.51 Significantly, it was recently reported that after pancreatic
duct ligation of 8 week old mice, the highest proliferation of insulin-expressing cells had occurred in small
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islets of <20 b-cells, and which had derived from
Ngn3C cells within these small b-cell clusters.52 Our
data would suggest that such b-cells in mice represent,
in part, a population that has recently differentiated
from insulin¡ progenitors, which consequently did
not tag with HPAP.
As indicated by Murtaugh, 53 the study by Smukler
et al.5 used the inducible RIPCreER; Z/EG model to
tag b-cells and follow them in vivo: a model in which
only a subset of b-cells were tagged, and which, it has
been suggested, may inappropriately label a fraction of
acinar cells over an extended chase, raising concern
over RIPCreER transgene stringency. 54 The present
study used the non-inducible strain RIPCre to tag a
high proportion of b-cells with HPAP before islet isolation and in vitro culture. All lineage tracing experiments contain inherent limitations, including the
assumption of reporter indelibility without dilution,
and the theoretical possibility that Cre driven by a
minimal promoter may be subject to promiscuous
expression in non-native conditions, such as tissue
culture. As only ~0.2% of islet-derived cells present in
dedifferentiation culture after 1 week immunostained
for the b-cell reporter HPAP, we propose that this
number does not over-represent the surviving b-cell
population. The stoichiometric analysis is further
complicated by the relative rarity of the InsCGlut2LO
cell population, and the observation that in their primary location, the extra-islet endocrine clusters, fewer
neonatal b-cells immunostained for HPAP than did
those within islets. However, the cytoplasmic HPAP
reporter in our model required us to employ a proxy
b-cell marker, GPM6a 20 for cell sorting, thus we did
not sort b-cells based on a putatively random event.
Furthermore, while lineage tracing analyses were reliant on Cre-based reporter expression, InsCGlut2LO
cells themselves were identiﬁed in vivo and showed
differential expression based on age, providing physiological relevance and a future avenue for study. Also,
as demonstrated, not all InsCGlut2LO cells were multipotent. Thus we have identiﬁed InsCGlut2LO cells
using different techniques (FACS and immunoﬂuorescence), multiple markers for b-cells (insulin, GPM6a,
HPAP, and eYFP), and 2 separate antibodies for
Glut2, indicating that these ﬁndings are collectively
unlikely to represent artifact.
This work builds on evidence that the mouse and
human pancreas contain insulin-expressing multipotential cells, which can be identiﬁed by the absence
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of Glut2.4,5 Determining the fate of these progenitors
during maturation, and the age at which their numbers cease to be a feasible source of renewable insulinproducing cells, may elucidate the extent of postnatal
b-cell plasticity.
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